1 – 10 of 10
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Association of Annual N-Terminal Pro-Brain Natriuretic Peptide Measurements with Clinical Events in Patients with Asymptomatic Nonsevere Aortic Stenosis : A Post Hoc Substudy of the SEAS Trial
(
- Contribution to journal › Article
- 2016
-
Mark
Assessing optimal blood pressure in patients with asymptomatic aortic valve stenosis
(
- Contribution to journal › Article
- 2015
-
Mark
High sensitivity C reactive protein as a prognostic marker in patients with mild to moderate aortic valve stenosis during lipid-lowering treatment: an SEAS substudy.
(
- Contribution to journal › Article
- 2014
-
Mark
Adjusting parameters of aortic valve stenosis severity by body size
(
- Contribution to journal › Article
-
Mark
Indexing aortic valve area by body surface area increases the prevalence of severe aortic stenosis
(
- Contribution to journal › Article
- 2013
-
Mark
Prognostic importance of atrial fibrillation in asymptomatic aortic stenosis: The Simvastatin and Ezetimibe in Aortic Stenosis study
(
- Contribution to journal › Article
- 2011
-
Mark
Response to Letters Regarding Article, "Outcome of Patients With Low-Gradient "Severe" Aortic Stenosis and Preserved Ejection Fraction"
(
- Contribution to journal › Letter
-
Mark
Outcome of Patients With Low-Gradient "Severe" Aortic Stenosis and Preserved Ejection Fraction
(
- Contribution to journal › Article
- 2009
-
Mark
Impact of Severity of Aortic Valve Stenosis on Effect of Intensive Lipid-Lowering Therapy: The SEAS Study
2009) 58th Annual Scientific Session of the American-College-of-Cardiology In Journal of the American College of Cardiology 53(10). p.415-415(
- Contribution to journal › Published meeting abstract
- 2008
-
Mark
Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis
(
- Contribution to journal › Article